A Study to Evaluate JNJ-64565111 Pharmacokinetics and Safety in Adult Participants With Varying Degrees of Renal Function
Status:
Completed
Trial end date:
2018-12-17
Target enrollment:
Participant gender:
Summary
The purpose of study is to evaluate the pharmacokinetics of a single, subcutaneous dose of
JNJ-64565111 in adult participants with varying degrees of renal function including
participants with end stage renal disease, requiring hemodialysis, compared with participants
with normal renal function.